Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-18-000554

Director sold 920 shares at $12.51 ($11,509)

  • Director acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-05 Option exercise : show line 1 in the form −2,000 $5.75 $11,500 19,236 I
2018-06-05 Sale : show line 2 in the form −920 $12.51 $11,509 18,316 I
Open-market sales · 920 sh · avg $12.51 · $11,509

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-05 Option exercise : show line 3 in the form Warrant (right to buy) −2,000 0 I
Loading xslF345X03/crispr-fm4_jun42018.xml…